Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 2453 entries
Sorted by: Best Match Show Resources per page
Early Robotic Repair of Vesicouterine Fistula: A Case Report and Literature Review.

Urology case reports

Alamoudi OJ, AlTheneyan MA, Aldhaam N, Moazin M.
PMID: 28224086
Urol Case Rep. 2017 Feb 12;11:76-78. doi: 10.1016/j.eucr.2017.01.006. eCollection 2017 Feb.

As cesarean sections become a more common mode of delivery, they have become the most likely cause of vesicouterine fistula formation. The associated pathology with repeat cesarean deliveries may make repair of these fistulas difficult. Early robotic-surgery offers a...

Cite
Alamoudi OJ, AlTheneyan MA, Aldhaam N, et al. Early Robotic Repair of Vesicouterine Fistula: A Case Report and Literature Review. Urol Case Rep. 2017;11:76-78doi: 10.1016/j.eucr.2017.01.006.
Alamoudi, O. J., AlTheneyan, M. A., Aldhaam, N., & Moazin, M. (2017). Early Robotic Repair of Vesicouterine Fistula: A Case Report and Literature Review. Urology case reports, 1176-78. https://doi.org/10.1016/j.eucr.2017.01.006
Alamoudi, Othman J, et al. "Early Robotic Repair of Vesicouterine Fistula: A Case Report and Literature Review." Urology case reports vol. 11 (2017): 76-78. doi: https://doi.org/10.1016/j.eucr.2017.01.006
Alamoudi OJ, AlTheneyan MA, Aldhaam N, Moazin M. Early Robotic Repair of Vesicouterine Fistula: A Case Report and Literature Review. Urol Case Rep. 2017 Feb 12;11:76-78. doi: 10.1016/j.eucr.2017.01.006. eCollection 2017 Feb. PMID: 28224086; PMCID: PMC5310202.
Copy Download .nbib Format: NLM
Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.

American journal of cancer research

Kumar G, Patlolla JM, Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Singh A, Gillaspy A, Lightfoot S, Steele VE, Kopelovich L, Rao CV.
PMID: 27293987
Am J Cancer Res. 2016 May 01;6(5):894-909. eCollection 2016.

Lung cancer is the leading cause of cancer deaths worldwide. Targeting complementary pathways will achieve better treatment efficacy than a single agent high-dose strategy that could increase risk of side effects and tumor resistance. To target COX-2, 5-LOX, and...

Cite
Kumar G, Patlolla JM, Madka V, et al. Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. Am J Cancer Res. 2016;6(5):894-909
Kumar, G., Patlolla, J. M., Madka, V., Mohammed, A., Li, Q., Zhang, Y., Biddick, L., Singh, A., Gillaspy, A., Lightfoot, S., Steele, V. E., Kopelovich, L., & Rao, C. V. (2016). Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. American journal of cancer research, 6(5), 894-909.
Kumar, Gaurav, et al. "Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice." American journal of cancer research vol. 6,5 (2016): 894-909.
Kumar G, Patlolla JM, Madka V, Mohammed A, Li Q, Zhang Y, Biddick L, Singh A, Gillaspy A, Lightfoot S, Steele VE, Kopelovich L, Rao CV. Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. Am J Cancer Res. 2016 May 01;6(5):894-909. eCollection 2016. PMID: 27293987; PMCID: PMC4889708.
Copy Download .nbib Format: NLM
Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer.

Clinical Medicine Insights. Oncology

Osman MA, Hennessy BT.
PMID: 26628862
Clin Med Insights Oncol. 2015 Nov 24;9:105-12. doi: 10.4137/CMO.S32812. eCollection 2015.

STUDY OBJECTIVES: To compare breast cancer metastases between obese and nonobese women and to evaluate the effect of first-line metastatic chemotherapy in each group.METHOD: A retrospective study was performed in an educational institute in Ireland. The study consisted of...

Cite
Osman MA, Hennessy BT. Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer. Clin Med Insights Oncol. 2015;9:105-12doi: 10.4137/CMO.S32812.
Osman, M. A., & Hennessy, B. T. (2015). Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer. Clinical Medicine Insights. Oncology, 9105-12. https://doi.org/10.4137/CMO.S32812
Osman, Mohammed A, and Hennessy, Bryan T. "Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer." Clinical Medicine Insights. Oncology vol. 9 (2015): 105-12. doi: https://doi.org/10.4137/CMO.S32812
Osman MA, Hennessy BT. Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer. Clin Med Insights Oncol. 2015 Nov 24;9:105-12. doi: 10.4137/CMO.S32812. eCollection 2015. PMID: 26628862; PMCID: PMC4659439.
Copy Download .nbib Format: NLM
Radiotherapy vs. Radiosurgery in Treating Patients with Acromegaly: Systematic Review and Meta-Analysis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Abu Dabrh A, Asi N, Farah W, Mohammed K, Wang Z, Farah M, Prokop L, Katznelson L, Murad M.
PMID: 25786558
Endocr Pract. 2015 Mar 18;1-33. doi: 10.4158/EP14574.RA. Epub 2015 Mar 18.

OBJECTIVE: When patients with acromegaly have residual disease following surgery, adjuvant radiation therapy is considered. Both stereotactic radiosurgery (SRS) and conventional fractionated radiotherapy (RT) are utilized. We conducted a systematic review and meta-analysis to synthesize the existing evidence to...

Cite
Abu Dabrh A, Asi N, Farah W, et al. Radiotherapy vs. Radiosurgery in Treating Patients with Acromegaly: Systematic Review and Meta-Analysis. Endocr Pract. 2015;1-33doi: 10.4158/EP14574.RA.
Abu Dabrh, A., Asi, N., Farah, W., Mohammed, K., Wang, Z., Farah, M., Prokop, L., Katznelson, L., & Murad, M. (2015). Radiotherapy vs. Radiosurgery in Treating Patients with Acromegaly: Systematic Review and Meta-Analysis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1-33. https://doi.org/10.4158/EP14574.RA
Abu Dabrh, Abd, et al. "Radiotherapy vs. Radiosurgery in Treating Patients with Acromegaly: Systematic Review and Meta-Analysis." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. (2015): 1-33. doi: https://doi.org/10.4158/EP14574.RA
Abu Dabrh A, Asi N, Farah W, Mohammed K, Wang Z, Farah M, Prokop L, Katznelson L, Murad M. Radiotherapy vs. Radiosurgery in Treating Patients with Acromegaly: Systematic Review and Meta-Analysis. Endocr Pract. 2015 Mar 18;1-33. doi: 10.4158/EP14574.RA. Epub 2015 Mar 18. PMID: 25786558.
Copy Download .nbib Format: NLM
Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from .

ACS biomaterials science & engineering

Wo Y, Brisbois EJ, Wu J, Li Z, Major TC, Mohammed A, Wang X, Colletta A, Bull JL, Matzger AJ, Xi C, Bartlett RH, Meyerhoff ME.
PMID: 28317023
ACS Biomater Sci Eng. 2017 Mar 13;3(3):349-359. doi: 10.1021/acsbiomaterials.6b00622. Epub 2017 Jan 22.

Nitric oxide (NO) has many important physiological functions, including its ability to inhibit platelet activation and serve as potent antimicrobial agent. The multiple roles of NO in vivo have led to great interest in the development of biomaterials that...

Cite
Wo Y, Brisbois EJ, Wu J, et al. Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from . ACS Biomater Sci Eng. 2017;3(3):349-359doi: 10.1021/acsbiomaterials.6b00622.
Wo, Y., Brisbois, E. J., Wu, J., Li, Z., Major, T. C., Mohammed, A., Wang, X., Colletta, A., Bull, J. L., Matzger, A. J., Xi, C., Bartlett, R. H., & Meyerhoff, M. E. (2017). Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from . ACS biomaterials science & engineering, 3(3), 349-359. https://doi.org/10.1021/acsbiomaterials.6b00622
Wo, Yaqi, et al. "Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from ." ACS biomaterials science & engineering vol. 3,3 (2017): 349-359. doi: https://doi.org/10.1021/acsbiomaterials.6b00622
Wo Y, Brisbois EJ, Wu J, Li Z, Major TC, Mohammed A, Wang X, Colletta A, Bull JL, Matzger AJ, Xi C, Bartlett RH, Meyerhoff ME. Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from . ACS Biomater Sci Eng. 2017 Mar 13;3(3):349-359. doi: 10.1021/acsbiomaterials.6b00622. Epub 2017 Jan 22. PMID: 28317023; PMCID: PMC5351555.
Copy Download .nbib Format: NLM
Molecular Targeted Intervention for Pancreatic Cancer.

Cancers

Mohammed A, Janakiram NB, Pant S, Rao CV.
PMID: 26266422
Cancers (Basel). 2015 Aug 10;7(3):1499-542. doi: 10.3390/cancers7030850.

Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is associated with westernized diet, tobacco, alcohol, obesity, chronic pancreatitis, and family history of pancreatic cancer. New targeted agents and the use of various...

Cite
Mohammed A, Janakiram NB, Pant S, et al. Molecular Targeted Intervention for Pancreatic Cancer. Cancers (Basel). 2015;7(3):1499-542doi: 10.3390/cancers7030850.
Mohammed, A., Janakiram, N. B., Pant, S., & Rao, C. V. (2015). Molecular Targeted Intervention for Pancreatic Cancer. Cancers, 7(3), 1499-542. https://doi.org/10.3390/cancers7030850
Mohammed, Altaf, et al. "Molecular Targeted Intervention for Pancreatic Cancer." Cancers vol. 7,3 (2015): 1499-542. doi: https://doi.org/10.3390/cancers7030850
Mohammed A, Janakiram NB, Pant S, Rao CV. Molecular Targeted Intervention for Pancreatic Cancer. Cancers (Basel). 2015 Aug 10;7(3):1499-542. doi: 10.3390/cancers7030850. PMID: 26266422; PMCID: PMC4586783.
Copy Download .nbib Format: NLM
Patients' Perceptions Towards the Participation of Medical Students in their Care.

Sultan Qaboos University medical journal

Ghobain MA, Alghamdi A, Arab A, Alaem N, Aldress T, Ruhyiem M.
PMID: 27226915
Sultan Qaboos Univ Med J. 2016 May;16(2):e224-9. doi: 10.18295/squmj.2016.16.02.014. Epub 2016 May 15.

OBJECTIVES: Patient interaction is a vital part of healthcare training. This study aimed to investigate patients' perceptions of the participation of medical students in their care.METHODS: This descriptive cross-sectional study was conducted between October 2014 and March 2015 among...

Cite
Ghobain MA, Alghamdi A, Arab A, et al. Patients' Perceptions Towards the Participation of Medical Students in their Care. Sultan Qaboos Univ Med J. 2016;16(2):e224-9doi: 10.18295/squmj.2016.16.02.014.
Ghobain, M. A., Alghamdi, A., Arab, A., Alaem, N., Aldress, T., & Ruhyiem, M. (2016). Patients' Perceptions Towards the Participation of Medical Students in their Care. Sultan Qaboos University medical journal, 16(2), e224-9. https://doi.org/10.18295/squmj.2016.16.02.014
Ghobain, Mohammed Al, et al. "Patients' Perceptions Towards the Participation of Medical Students in their Care." Sultan Qaboos University medical journal vol. 16,2 (2016): e224-9. doi: https://doi.org/10.18295/squmj.2016.16.02.014
Ghobain MA, Alghamdi A, Arab A, Alaem N, Aldress T, Ruhyiem M. Patients' Perceptions Towards the Participation of Medical Students in their Care. Sultan Qaboos Univ Med J. 2016 May;16(2):e224-9. doi: 10.18295/squmj.2016.16.02.014. Epub 2016 May 15. PMID: 27226915; PMCID: PMC4868523.
Copy Download .nbib Format: NLM
MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells.

American journal of cancer research

Khodayari N, Mohammed KA, Lee H, Kaye F, Nasreen N.
PMID: 27725905
Am J Cancer Res. 2016 Sep 01;6(9):1996-2009. eCollection 2016.

MicroRNAs belonging to the miR-302 family are emerging as key players in the control of cell growth, and maintaining pluripotency during cell fate determination and differentiation in embryonic stem cells. However, the mechanisms whereby ephA2/ephirnA1 signaling regulates miR-302b expression...

Cite
Khodayari N, Mohammed KA, Lee H, et al. MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. Am J Cancer Res. 2016;6(9):1996-2009
Khodayari, N., Mohammed, K. A., Lee, H., Kaye, F., & Nasreen, N. (2016). MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. American journal of cancer research, 6(9), 1996-2009.
Khodayari, Nazli, et al. "MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells." American journal of cancer research vol. 6,9 (2016): 1996-2009.
Khodayari N, Mohammed KA, Lee H, Kaye F, Nasreen N. MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. Am J Cancer Res. 2016 Sep 01;6(9):1996-2009. eCollection 2016. PMID: 27725905; PMCID: PMC5043109.
Copy Download .nbib Format: NLM
Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium.

Parasites & vectors

Webster BL, Rabone M, Pennance T, Emery AM, Allan F, Gouvras A, Knopp S, Garba A, Hamidou AA, Mohammed KA, Ame SM, Rollinson D, Webster JP.
PMID: 26453014
Parasit Vectors. 2015 Oct 09;8:519. doi: 10.1186/s13071-015-1134-5.

Unfortunately, the original version of this article [1], contained a mistake. In Table 1, the primers for Sh6 and Sh9 were included incorrectly. Instead of GGGATGTATGCAGACTTG TTGTTTGGCTGCAGTAAC and GCTGAGCTTGAGATTG CTTCTGTCCCATCGATACC they should have been Sh6 Forward Primer GGTGGATTACGCAATAG, Sh6...

Cite
Webster BL, Rabone M, Pennance T, et al. Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium. Parasit Vectors. 2015;8:519doi: 10.1186/s13071-015-1134-5.
Webster, B. L., Rabone, M., Pennance, T., Emery, A. M., Allan, F., Gouvras, A., Knopp, S., Garba, A., Hamidou, A. A., Mohammed, K. A., Ame, S. M., Rollinson, D., & Webster, J. P. (2015). Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium. Parasites & vectors, 8519. https://doi.org/10.1186/s13071-015-1134-5
Webster, B L, et al. "Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium." Parasites & vectors vol. 8 (2015): 519. doi: https://doi.org/10.1186/s13071-015-1134-5
Webster BL, Rabone M, Pennance T, Emery AM, Allan F, Gouvras A, Knopp S, Garba A, Hamidou AA, Mohammed KA, Ame SM, Rollinson D, Webster JP. Erratum to: Development of novel multiplex microsatellite polymerase chain reactions to enable high-throughput population genetic studies of Schistosoma haematobium. Parasit Vectors. 2015 Oct 09;8:519. doi: 10.1186/s13071-015-1134-5. PMID: 26453014; PMCID: PMC4600265.
Copy Download .nbib Format: NLM
Erratum to: Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.

Cardiovascular and interventional radiology

Chan LS, Sze DY, Poultsides GA, Louie JD, Abdelrazek Mohammed MA, Wang DS.
PMID: 28534185
Cardiovasc Intervent Radiol. 2017 Oct;40(10):1657. doi: 10.1007/s00270-017-1701-6.

No abstract available.

Cite
Chan LS, Sze DY, Poultsides GA, et al. Erratum to: Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. Cardiovasc Intervent Radiol. 2017;40(10):1657doi: 10.1007/s00270-017-1701-6.
Chan, L. S., Sze, D. Y., Poultsides, G. A., Louie, J. D., Abdelrazek Mohammed, M. A., & Wang, D. S. (2017). Erratum to: Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. Cardiovascular and interventional radiology, 40(10), 1657. https://doi.org/10.1007/s00270-017-1701-6
Chan, Lauren S, et al. "Erratum to: Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma." Cardiovascular and interventional radiology vol. 40,10 (2017): 1657. doi: https://doi.org/10.1007/s00270-017-1701-6
Chan LS, Sze DY, Poultsides GA, Louie JD, Abdelrazek Mohammed MA, Wang DS. Erratum to: Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma. Cardiovasc Intervent Radiol. 2017 Oct;40(10):1657. doi: 10.1007/s00270-017-1701-6. PMID: 28534185.
Copy Download .nbib Format: NLM
Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Richard PO, Ahmad AE, Bashir S, Zlotta A, Bhindi B, Leao R, Nayan M, Mohammed A, Fleshner NE, Kulkarni GS.
PMID: 29485035
Can Urol Assoc J. 2018 Jun;12(6):203-210. doi: 10.5489/cuaj.4870. Epub 2018 Feb 23.

INTRODUCTION: Non-muscle-invasive bladder cancer (NMIBC) accounts for 75-85% of all urothelial bladder cancers (UBC). Many UBC patients are also afflicted by diabetes mellitus (DM). It has been postulated that several oral hypoglycemic agents could impact disease-specific survival (DSS), but...

Cite
Richard PO, Ahmad AE, Bashir S, et al. Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Can Urol Assoc J. 2018;12(6):203-210doi: 10.5489/cuaj.4870.
Richard, P. O., Ahmad, A. E., Bashir, S., Zlotta, A., Bhindi, B., Leao, R., Nayan, M., Mohammed, A., Fleshner, N. E., & Kulkarni, G. S. (2018). Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 12(6), 203-210. https://doi.org/10.5489/cuaj.4870
Richard, Patrick O, et al. "Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 12,6 (2018): 203-210. doi: https://doi.org/10.5489/cuaj.4870
Richard PO, Ahmad AE, Bashir S, Zlotta A, Bhindi B, Leao R, Nayan M, Mohammed A, Fleshner NE, Kulkarni GS. Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis. Can Urol Assoc J. 2018 Jun;12(6):203-210. doi: 10.5489/cuaj.4870. Epub 2018 Feb 23. PMID: 29485035; PMCID: PMC5994977.
Copy Download .nbib Format: NLM
Benign mass in tonsil- cavernous hemangioma.

Journal of clinical and diagnostic research : JCDR

Joseph S, Prakash M, Mohammed HK, Govar A.
PMID: 24298502
J Clin Diagn Res. 2013 Oct;7(10):2284-5. doi: 10.7860/JCDR/2013/5278.3497. Epub 2013 Oct 05.

Cavernous hemangioma is also called as 'ANGIOMA CAVERNOSUM' or 'CAVERNOMA' as benign lesion of blood vessels. They are similar to strawberry hemangioma but deeply situated. Although most often associated with skin it is also sometimes found in mucous membrane,...

Cite
Joseph S, Prakash M, Mohammed HK, et al. Benign mass in tonsil- cavernous hemangioma. J Clin Diagn Res. 2013;7(10):2284-5doi: 10.7860/JCDR/2013/5278.3497.
Joseph, S., Prakash, M., Mohammed, H. K., & Govar, A. (2013). Benign mass in tonsil- cavernous hemangioma. Journal of clinical and diagnostic research : JCDR, 7(10), 2284-5. https://doi.org/10.7860/JCDR/2013/5278.3497
Joseph, Sumitha, et al. "Benign mass in tonsil- cavernous hemangioma." Journal of clinical and diagnostic research : JCDR vol. 7,10 (2013): 2284-5. doi: https://doi.org/10.7860/JCDR/2013/5278.3497
Joseph S, Prakash M, Mohammed HK, Govar A. Benign mass in tonsil- cavernous hemangioma. J Clin Diagn Res. 2013 Oct;7(10):2284-5. doi: 10.7860/JCDR/2013/5278.3497. Epub 2013 Oct 05. PMID: 24298502; PMCID: PMC3843388.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 2453 entries